I need to check the filing content for substantive disclosure beyond boilerplate. The filing includes financial statements, an MD&A section, and other substantive content referenced in the table of contents. However, the actual financial data (balance sheets, income statements, etc.) appears to be cut off before the numbers are provided. Let me assess what substantive content exists. The filing does contain some substantive facts: the quarterly period ended October 4, 2026, shares outstanding of 212,206,365 as of November 6, 2026, the company is a large accelerated filer, and it references forward-looking items about restructuring, warrant dividends, convertible notes repurchases, and CEO transition. However, the actual financial figures are not included in the extracted text. I'll work with what's available.

Enovix Corporation filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 13, 2026, covering the fiscal quarter ended October 4, 2026.

Key Highlights

  • Reporting period: The filing covers the fiscal quarter ended October 4, 2026, with comparative periods ended September 28, 2025.
  • Shares outstanding: As of November 6, 2026, 212,206,365 shares of common stock, par value $0.0001 per share, were issued and outstanding, according to the filing.
  • Filer status: Enovix is classified as a large accelerated filer, as indicated on the cover page of the filing.
  • CEO transition disclosed: The filing identifies the company's "ability to successfully transition the Chief Executive Officer role and/or attract a permanent successor for such role" as a forward-looking matter subject to risks and uncertainties.
  • Warrant dividend and notes repurchases: The filing references anticipated warrant dividends and repurchases of Convertible Senior Notes and common stock among its forward-looking disclosures.
  • Restructuring referenced: The company's ability "to manage and achieve the benefits of our restructuring efforts" is listed among forward-looking topics subject to material risks.

Enovix Q3 2026 Quarterly Filing: Key Disclosures and Forward-Looking Topics

Enovix Corporation (NASDAQ:ENVX), a Delaware-incorporated battery technology company headquartered at 3501 W Warren Avenue, Fremont, California 94538, filed its Form 10-Q for the fiscal quarter ended October 4, 2026. As of November 6, 2026, the company reported 212,206,365 shares of common stock outstanding at a par value of $0.0001 per share. The filing was submitted under the Nasdaq Global Select Market listing for common stock with trading symbol ENVX.

The filing's forward-looking statements section identifies several areas of focus management considers subject to risks and uncertainties. These include the company's ability to build and scale manufacturing lines for lithium-ion batteries, to meet customer milestones for products described as "AI and MX(TM)" products, and to manage expenses and realize cost savings goals. The company also disclosed, as a forward-looking matter, its efforts to "successfully transition the Chief Executive Officer role and/or attract a permanent successor for such role," without providing further detail on the status of that transition within the extracted text.

Additional forward-looking topics identified in the filing include expectations regarding an anticipated warrant dividend and its impact on the company's capital structure and indebtedness, repurchases of Convertible Senior Notes and common stock, and the company's ability to align with customer demand for "geodiversity and supply chain resilience." The filing states that forward-looking statements "involve a number of risks and uncertainties, some of which are beyond our control," and that the company undertakes no obligation to update such statements except as required by law. Detailed financial statements covering the fiscal quarter and fiscal year-to-date periods were included in the filing but are not fully reproduced in the extracted text above.

What Was Disclosed

Enovix Corporation submitted a Form 10-Q for the fiscal quarter ended October 4, 2026, disclosing 212,206,365 shares outstanding as of November 6, 2026, a large accelerated filer classification, and forward-looking matters including a CEO transition and anticipated warrant dividend.